<SEC-DOCUMENT>0001193125-18-040507.txt : 20180213
<SEC-HEADER>0001193125-18-040507.hdr.sgml : 20180213
<ACCEPTANCE-DATETIME>20180212182636
ACCESSION NUMBER:		0001193125-18-040507
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180212
FILED AS OF DATE:		20180213
DATE AS OF CHANGE:		20180212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DBV Technologies S.A.
		CENTRAL INDEX KEY:			0001613780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36697
		FILM NUMBER:		18598449

	BUSINESS ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
		BUSINESS PHONE:		33(0)155427878

	MAIL ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d523418d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Month of February 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-36697</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DBV TECHNOLOGIES S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F:</FONT>
<FONT STYLE="white-space:nowrap">&#9746;&nbsp;&nbsp;Form&nbsp;20-F&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT LIST </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated February&nbsp;12, 2018.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>DBV TECHNOLOGIES S.A.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: February&nbsp;12, 2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Schilansky</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Deputy Chief Executive Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g523418img001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Press Release </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Montrouge, France, February 12, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV
Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies (Euronext: DBV &#150; ISIN: FR0010417345
&#150; Nasdaq Stock Market: DBVT) today announced that the Company will present data highlighting its Viaskin technology platform at the 2018 American Academy of Allergy, Asthma&nbsp;&amp; Immunology (AAAAI)/World Allergy Organization (WAO) Joint
Congress Meeting in Orlando, Florida, March 2-5, 2018. The abstracts became available on the <U>AAAAI/WAO&nbsp;Joint Congress website</U> at 9:00 AM ET on February 12. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Four abstracts have been accepted for poster presentation, including a late-breaking abstract on the topline results from the Company&#146;s PEPITES (Peanut
EPIT Efficacy and Safety) Phase III trial. These results were previously released by the Company in October 2017. The PEPITES trial evaluated the safety and efficacy of Viaskin Peanut in children four to 11 years of age. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;As we head into AAAAI/WAO, we are excited to once again present data and discuss the PEPITES topline results with the medical
community,&#148;</I>&nbsp;said<B>&nbsp;Dr.</B><B></B><B>&nbsp;Pierre-Henri Benhamou</B>, Chairman&nbsp;&amp;&nbsp;Chief Executive Officer of DBV Technologies.<I>&nbsp;&#147;Viaskin Peanut has been granted Fast Track and Breakthrough Therapy
Designation by the FDA, and we look forward to offering this treatment to patients as soon as possible, if approved.&#148;</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Presentation and abstract
details are as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Viaskin Peanut Clinical Data </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>&#147;Effect of epicutaneous immunotherapy on inducing peanut desensitization of peanut-allergic children: topline peanut epicutaneous immunotherapy efficacy and safety (PEPITES),&#148;</I></B> presenting author:
Dr.&nbsp;David Fleischer, Director, Allergy and Immunology Center and Associate Section Head, Children&#146;s Hospital Colorado: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Poster Number: L32 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Session Number: 4215 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Date/Time: Monday, March&nbsp;5, 2018, 9:45 AM &#150; 10:45 AM ET </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Location: Convention Center, South Concourse, Level&nbsp;1, South Hall A2 </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Epicutaneous Immunotherapy
(EPIT) Mechanism of Action Data </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>&#147;Unique epigenetic signature in T cell compartment after epigenetic immunotherapy in peanut sensitized mice,&#148; </I></B>presenting author: Dr.&nbsp;Lucie Mondoulet, DBV Technologies: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Poster Number: 381 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Session Number: 3203 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Date/Time: Sunday, March&nbsp;4, 2018, 9:45 AM &#150; 10:45 AM ET </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Location: Convention Center, South Concourse, Level&nbsp;1, South Hall A2 </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g523418img022.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>&#147;Epicutaneous immunotherapy with peanut directly targets Langerhans cells in human skin,&#148; </I></B>presenting author: Dr.&nbsp;Vincent Dioszeghy, DBV Technologies: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Poster Number: 723 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Session Number: 4204 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Date/Time: Monday, March&nbsp;5, 2018, 9:45 AM &#150; 10:45 AM ET </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Location: Convention Center, South Concourse, Level&nbsp;1, South Hall A2 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>&#147;Phenotypic changes and IDO over-expression in splenic dendritic cells after epicutaneous immunotherapy,&#148; </I></B>presenting author: Dr.&nbsp;Benjamin Pelletier, DBV Technologies: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Poster Number: 728 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Session Number: 4204 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Date/Time: Monday, March&nbsp;5, 2018, 9:45 AM &#150; 10:45 AM ET </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Location: Convention Center, South Concourse, Level&nbsp;1, South Hall A2 </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About PEPITES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Peanut EPIT Efficacy and Safety Study (PEPITES) was a global, pivotal, double-blinded, placebo-controlled Phase III trial designed to evaluate the safety
and efficacy of Viaskin Peanut 250 &micro;g in children ages four to 11 years. PEPITES was conducted in 31 centers across North America (Canada and the United States), Germany, Ireland and Australia. Topline results from PEPITES were announced in
October 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During PEPITES, patients&#146; response has been assessed using a double-blind, placebo controlled food challenge (DBPCFC). Patients were
randomized 2:1 to receive either Viaskin Peanut 250 &micro;g or placebo for 12 months. The primary endpoint was based on a responder analysis after 12 months of treatment with Viaskin Peanut 250 &micro;g. For patients with a baseline peanut protein
eliciting dose (ED) equal to or less than 10 mg, a responder was defined as a patient with a peanut protein ED equal to or greater than 300 mg of peanut protein after 12 months of treatment. For patients with a baseline ED greater than 10 mg, a
responder was defined as a patient with a peanut protein ED equal to or greater than 1,000 mg of peanut protein after 12 months of treatment. As a secondary efficacy endpoint, Cumulative Reactive Dose (CRD), has also been used in PEPITES to
establish the total quantity of peanut protein that triggers patient reactions at month 12 of active treatment versus placebo. Serological markers were also measured at baseline, 3, 6, and 12 months in order to characterize the immunological changes
in patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DBV Technologies</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies
is developing Viaskin<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, DBV&#146;s method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and
<FONT STYLE="white-space:nowrap">non-invasive</FONT> product candidates, the company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV&#146;s food allergies programs include
ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> clinical study of
Viaskin Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. Company shares
are traded on segment A of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and traded on the Nasdaq Global Select Market in the form of American Depositary Shares (each representing
<FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share) (Ticker: DBVT). For more information on DBV Technologies, please visit our website: <U><FONT STYLE="white-space:nowrap">www.dbv-technologies.com</FONT></U> </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g523418img022.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may contain forward-looking statements and estimates, including statements regarding the potential of Viaskin Peanut and the regulatory
posture of Viaskin Peanut. These forward-looking statements and estimates are not promises or guarantees and involve substantial risks and uncertainties. At this stage, the products of the Company have not been authorized for sale in any country.
Among the factors that could cause actual results to differ materially from those described or projected herein include uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals
and the risk that historical clinical results in one patient population may not be predictive of future clinical trial results in different patient populations. A further list and description of these risks, uncertainties and other risks can be
found in the Company&#146;s regulatory filings with the French Autorit&eacute; des March&eacute;s Financiers, the Company&#146;s Securities and Exchange Commission filings and reports, including in the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2016 and future filings and reports by the Company. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and
estimates, which speak only as of the date hereof. Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Investor Relations Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sara Blum Sherman
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Investor Relations&nbsp;&amp; Strategy </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;212-271-0740</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">sara.sherman@dbv-technologies.com</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Media Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Roberta Di Giorgio </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;917-612-2861</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">roberta.digiorgio@dbv-technologies.com</FONT></U> </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g523418img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g523418img001.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M&=WE]J5+<ZFKW"A8ATVXZXIOD.\33(&6VSN\O=P1]*<L+70>6VS'#T*AL9H
M(X?[5/RA(A&H' ZT+&;V1;<!(S$#EASGG_Z]"QF[;-H##M7#$-C-(L?G-'%
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MKF%0N&PV,FFQQ_:&5+93#+&N'8-@_2@ CC-P19A45HV.9.]#1F-C9;4)9O\
M64D<9DQ!&I2Y5B6D#?F:7R]I,+(6NBW$F?ZT $L9L,PD)*91@,1TISP'3&!8
M),'&WD=#39(S;[TN%,LC_<8MFE:%K5@;H&;<NU<MG'M0 - =-\JX;;*#_#Z9
MYH%FT4:79V$9#>7@X&?QI/)>U\J2Y#20YX4G.WTXI5MY$C69@QMLY\O=P!0
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M_P#K4,A@D-EM5VD.1)_GZ_SH\LLR0*I6Z5LF3=2LGELUO(I:Z9@RN3S]?PH
M62(Z>QB*I)YN &(Z420G2L.P27<",'M0T9MV9+A3+(XPC%LT/"UKAKH-,I7
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MZ4P'K:G4@TX"1CIM'>FPQ_VLV5"0^6H!P.M+Y#W&^2V!CBQRH;&:2.,WC9M
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MI)V;N@^M(RJ;@2!#]BW<^F?7Z40;99A%([?9U)V'.,TC!1<^2';[)NY/OZ4
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M_C%HDVQA;P+/-N;HB"-AD_B?UKSS3+5]5N1"XDEF8!8XU!RWT ZU[AI&D_\
M"D? EY+J,F/%OB"$VEG9@_/;6Y^\Q]&/'Y#TJ,7/]VZ2^*6B^?7Y%86+]HJC
MVCJ_Z\RCX#F2/PG\6=6?C3)Q'%'OZ,QE8_R85XS)L:<O&A-J"-VWI^%>R>.[
M2+X;_"S1O"$CE=2U6;^T;]<\QC'R(?T_*J?A'X4:;I&BGQ-XTNGL- ;!@L0<
M2W1[>X%84JL*<957M)Z>=DEI]QM4IRJ.--;I:^5W?]3RJ2U:^DQIT$DP RXA
M0GC/H*DU*QD@,*QVLL#D9.Y"I([]>]>KZO\ M#7&AXL_!^BZ=HU@G3]PLCD>
MK$CK7$?$+XB:MXZGL9[Z>*6:W1D3[/"L>%;!).!ST%==.=:4O>A9>NOY?J<T
MX4HKW97?II_7R.9E\J2");=<77'08(..I_&AOL_V7RPA^TY^[CYNM)(D<,$,
MMNY-P>@SG)]/SH:.#[)YPD;S]V<YYSGTKJ.8(_)CMY$N%S=<]1R3[4MOY4*N
M+Q?GQ\N[G\J;&D4UM++.Y$XSD9Q@]J=;)'=*[73L'4<9..* &VH2*3-TI\LC
MY-XR,9HC"+<!Y5(M#G;NZ#Z_I1:A;F3;<.VQ1^[R<<4D6V2X6)W;[*"=A]30
M I5/M1D"$V6X9].G7Z=:+@)).6MU)MQC?LX!YI&"K<F#>WV,L,GW]*+D+!.8
MX7;R6QYG.<4 .N_+FP+->0/GV#''I]:)_+EBC6T7$_? Z?6B[5;7'V5V)8?-
M@YX]:+B-+>*)[5B9CV!SF@ D\AK54B0_:<@8'WJ4&%;5TD3_ $OGJ.2?4>U-
MDCA2U26.1O/SUSSGZ4HCB>TDF=S]I')&<8;L* %M_+B25;Q29C]W=R2,=CZT
MVT"0NWVQ>"!L+C(QZ4ZWCCN$F>Z<B4>IQQCTIMFJW4C"Z9@57Y><<4 );*L<
MNZX4BW.?+W\@?6A0!<[V1OL>[\/K]*+4+-,(YG;R%SY?.,T* ;GR2[?9=W!]
MZ %G"--OA1OLP(W[>AI+P+,X-FN4"_/LX!'I1<;8IO*C=OLY(W]\47BBUDVV
MSMM9?WG.<"@"2Y\J8(+-?W@^]MXX[Y]ZZ6'7K!?AK>:-"6&IS7\4ZHJ_PJA!
M)/U-<S<I';!&M'8R$=CGY>YHDCBAMXY8'8S]L'K^%1**E:Y<9.-['3^-/$%E
MK>B^';: L]Y8Z=';2 I@JX/./:NV7XG:4NJ:C:M?7FGV]]8V\!O+8$2Q2QJ,
M$ $9&1@\UY!LB-GYV\_:<YZ_Q4Z&.*>&22XD83#KSCZ<5A+#PDE%]/\ .YM&
MO.+;77_ACT/Q!XBL[/P[<V-QXJU/Q%>W97'FEXX(T!R<JS'<3Q]*QOA=XNC\
M%ZY>/?R7-M8:A9O9M/ <2PJS*P9?<,H..XS7*VZQW1<W3MO5>,G'%-M=MQ,$
MG=O+5?W63C(]?YU2H1Y'!]276ESJ:Z'I>I>([/3]'OO-\8:OX@>['EP09DBA
MB4GEI,L=W'&WI6CX\TWPUK#Z";S59M(GM],M1+NMS+%,IC!!7!&"!Q7D4(22
M;RG=OLP8[#GK5B_OIKZ\5)[J6:! L09V)PJC 7/H*R^KV:<96^[_ "L:>WNF
MFOS_ .'/29?'VB^9=VEDLXTFUT:33K>1D^:5F.=Q Z9/;M5+5IO#'CY+"\?5
MY-$U*"W2"Z0VQECD5!@,I!&#MXP:\[N@MO(4@=O+;'F<YQ3[E8[5D^S.V67Y
ML'/R^M4L/&.L6TR77E+22NCOM%U;PK87NLZ+;7%ZFDZI9K:&^,8,D<BLCB1D
M&/EW)TSG!ZU6UZ^T#1? O_".Z/?/JU_=7L=W<7 A,2IL1E10"23]]C[<5Q,R
MQV\<#VKDS'T.<\>E+Y<"VJ3)(QN,YZ\[N]5[%7O=_P#!747MG:UD>C+\0-)L
M_%T5Y)%+<V\NE0Z;=*!B4CR$1RON"N??%3^$?^$)\$ZT^I76N7&I3>7(+:,6
MA1D+(0"Q)/KVKS&)(I;5Y97(N,G/..>U%NJ7$<KW3$2@=,XJ7AXVY4VM+%*N
MT[M)ZW.M\0>(-/OO"_AVQ?>9K19]XD7@;G!7\<5T>C_$JQT?6M-<RW5OILNA
MC2Y[B#Y98'\QVW+ZX)4^]>7VBI=-_I+L-H^3)QQZTRW FN!%,[>0N?+/3-5+
M#PE'E>VOXDJO.,N9>7X'INK>)+.ST?4=_B_5O$)O%\B&!3)%!$I(W-)ECNR,
MC;TY-5=4F\,>/&M-4NM7GT>ZAMH;:]B^S&5)O*145XR&&,JHR#WKSW"_:O(+
MM]CW<'/&<>OUHF58;AHHG;[.V/,/7!]*2PZCJF[]]/\ *PW6<M&M/G_PYZ@?
M'FB:KK%]INVXMO#LVEQZ7'<(NZ2)8R-CD=^1R/>L_4M0\/:5X6'A_2-2EU%[
MR[2>[NX;?RQ$B]  3DFN!O%6W<"V=MK#]Y@YP/6BX1+5$:U=C*1V.:%AXJUF
M[?Y=0]O)[H] \?>(-)OO"-AI-IJLWB#4H+C,-U- 8Y((<8\LL22><>PQ57PC
MXJTS2/"!T^Z9UU#^U[:[VA<G:F_)_P#'A7$21Q0VL<L+L9\C'.>>_%*L<369
MF9R+G.>O\5-4(\G)?K<7MI<_.>@Z1XRTS3OBQKFO7+R+#/<:@\,A7+D2QRK'
M@?5UK&\):]9Z/X>\5V>HEDGU&WB2W!7(;;)NQ[8%<Q#''<0S27+D3 \C.,?A
M1;JETS_:G8,JX7)Q\OK3]C'\OPU0O;2_/\3OYO&&G2?%BQUZ=Y/[,B:$H[KR
MH50#Q6=X>\265CXRUC4[II!874=TD;%<Y+YV\5QUF!<2;+AV$:C]WDXS3H]C
MS"%G;[,&.WGC\Z/81M;RL'MI7OYW/1+FY\,^,]/T.XO]7FTB73(5M9XOLID2
M=%8E60@C!Y(YINO>.=-UA?&SVB2I%J%O:06R[>2L4D0&?0[(\UYW-MCN/)1V
M-J6&_P!,T76VWF*0.WE,/WO? ]?Y5*P\;WN_\M;_ *%>WE;;^K6.ZT+QI::'
MX/6#3QNU2#6[74TC"X0I$C@Y/U(&/>M"5O ][KR:_'JEU%^^^UMI:6W[[?G=
MY?F9QC/\77%>;W*I:NAM78LRG=@YX_SFEFCB@ACDMY&,IZ8.?TIN@FW)-IL2
MK.R35['<2^.;/5-+\9-.AAU/66C:*)%S\P<DY/H!BL[Q=K]CJVGZ# I9[FRL
M$MY R_-O#$G![]:Y8I$+)9@Y^TY]?XJ58XI+>665R)Q[]_I51HQB[K^M+$NK
M*2L_ZUN>NQ?$S2H=<U>W>]O-.L]2L+6 7MN")(I8T7G&1D9!!YZ&LK5_$EEI
M^C/:7/BK5/$5U=2QMF4NEO%&IR05+'>Q('7IBO-[=([I9&NG(E Z$XXHM%6Z
MD(N7;"J/+R<9'>LEA81=UY?@:/$3DK,] _X3RQC^*GB'6+E)9] U=[J!B!AA
M#(W# =B,*??%7O"?_"%^#=8GU4ZW<:E"\$T=O#':%!&S(1N<ECGKC KR^ ++
M,(I7;[.I/E\X'6CY?M'D[V^R;NOOZ4WAXM<J;2M82KM/F:3=[GJVLZ?X?UCP
M+X42\U"72I$CF=)UA,D3IYG*D @@YYS7.>*O$5E'I^CZ+X7DFN+;3YFN9+O9
ML,LK8^ZO88%<IJ%]/(L%I]IDDLX1M"LV1&"<D#ZFHKAOL-PC6<C XRQ4Y(]Z
M(4.7XG?5NW34)5K[*VB7W'I?QKUZ.ZDTW2;&W^S7;!-0U..,XS=/&,Y]P.?^
M!M7.^!/$FEZ/_:%A?1R_9=5M#9W#VZ@RPG<KK( >N&0<>E<YJUW)=70O/M,E
MQ>3-NDD9MS-QR34$D<4=K'-"Y:YSP,]6[BJA04:2IL4JSE4]HCJ]0T7PCI.C
M7836KC5]4;BWBAMC$0<_><L3V[#\ZU]1O/"GC1XM2U?49=&U3RDCN[?[-YHD
M*C&^(Y&,^A[UYXD<369F>1A/NYYYSGTHA2.>&62Y<B<=1G&/2G[%[\SOWT_R
ML+VJVY5;MK_F>DW'C[2;@>)8I8I+6VGTV&PL$D&6=8VX+>YZUS\.NV2?#A=(
MN=PG_M/[4BLORB/RV7KZY(KE[15NMQNG8%1\N3CCUIMJ!<3".=V\I0?+YQFB
M-"$59>3^X)5I2W/8O!&O:7J.H^&(6266QTW0M3BO(P-O!2=R ?=2,&L+2)?"
MO@G4GU^PU:XUAHT9;2R6U\H*[*5#R$D\*"3@=37 V-]-I]]MM[F6"!E>+>C$
M95E*LN?0@X_$U7DVQW30HY^R$C>?0^G\ZR^K*[U=G_FW^II[=V6FJ_R2_0]"
MN-2T'QUHNEP7NHR:/>Z7%]G\U8#+#-#N+ 8!!##-;D/C+PKI-SX3M](FN9K;
M3!<_:)6BVEF<-SCW)Z5Y)<JMO,4@=MC >9@YP*+I4M=IM78N5YP<\53PT9:7
M=M=/7_AQ1Q$HZV5]-?0ZGPGKVGZ7=ZI)\R37-C<0(57)WNI S76^"_$BZ%\)
MK^]N+<MJ%E<-;Z3,3\Z2S(RR8^B@-]0*\HF2*&WBEMW8SGH,]?6K3WTDFC0P
M/=RE(Y#(D.X[5<\$@>N *=2@JGX?@*G6=/\ '\2NIA6WE2=<W?/49)/J*+?R
MH?,%XI\P_=W<G&.,>]"QQ36TLLSD7'4C/0]A^=);K'="5KIV$BCC)Q\N.#74
M<P682(_Z6OR%?DW\BDA"+-OF5OLI)V[N@HLU6Z;%R[85?DR<<40A99A%([?9
MP3LYQF@ 94^T"0(?L>[GT^OTHF"27!>!";< ;]O0\]J1@@N/)#M]E+<GW]*)
M]L-PT43MY# >9WQ0 MXL<S V2\!3OV<"GW'DRQHMHO[[J=HP1]?>F7@6U=1:
MNWS*=^#GCM3IHXK:-'M78RD= <\4 -;RFM$2)?\ 2_8?,#[TO[D6;(Z?Z7]/
MFS2-'%':)-&Y^T9XY[TNR)K1YF<_:,YZ]_I0 Z'R8XW6Z7]_VW<D_2F6>R%F
M^VKU4;-_(Q3H8XKB.1[EV\T=<G&!VIMFJW3,+MF!51MR<<4 /AA&IL\DSA67
M@<?K3;=?[38I,P"QC XZTJ0'4VDD4+%M^0@=\?TI(5.I-M4+#Y:XW+U- !$/
MM4GV5V'EH3@XZTC?+,+(,/*)^]C]*6-3<,+7:J-&3EQ367;)]AVJ6)SYG^>]
M "S?Z'+]FC8>7)C+8^[3KA1I;JL+ B12&']:;*OV20VQ59#+@!V_K2RQG3),
M,%F\Q2,MU% '=_#OXD3_  WD:VF4:GH%\=EYI\G(8'JZ^AKM+S07^&=]#X_\
M#3G5?#5R/WT ^8JI^]%(*\1D@.EA)F"R _+M],^E=;\/_B'JWPXD:[M62ZTV
MX'^DZ;-S%(O?CL:\^OAVVYT]WNNC_P"#YG=1KI6A4Z;/JO\ @>1ZE8Z%_;5R
MWC3X6:D+;49!ONM#D8!E;^)0O<>U0WWC+2=68OXW^&K)JL9(>:U0QLQ'<CI5
M6T\,^$O'UQ'K7@K7_P#A#]<<[VTV[D,:;O\ 88?R&:ZV.V^.&G*T0^PZO HQ
M&TCQ2@_J#^=>3)Q3M)ZK^9N,EY7ZGIQYFO=6GDE)?=T,3P[X]6YD>'P'\._L
M>H8"K=W$1D=,]QVXIS:?:^ =0'B3Q]J,>O\ B]OGLM)5P_EMGAG],>GMZUJS
MZ7\:O$<+07E[9^&+(#YY$EBC^IX)('TKF8Y/ WPUN/M%Q?)XY\71@E64EK:%
M_5F.=QY^OM1'EDVHZM](MMOUD]D$KQ2<M+=TDEZ16[)]/T(6\\WCWXE2AS<2
MF6PTM^'N&_ARO91V%>7?$+Q_JGCS7G>]G5;7.V&W3[D"=E JGXR\::O\0->D
MDU><37&[*[>$B7LJCM6&T9A<VA56+GAS7L4,/ROVE3XOP2[(\JM6YER0V_%O
MNQ+@?V:WEQ,"L@P?:G3QC2]CPN&+\'_&FS1G3BR$";S!C<W44LD)TLH[!9=_
MR@'M[?2NXXP>$64,=U&P>0\E?7C.*5K=5A^U^8OFYS[=>E(;<V*1W1PZ_>V>
MG?BD-FRQ?:OEQNSY?\/7% "I"+R&2ZD<+*,D#TQ2PQC4@TDSJK*,#_&FK;F^
MCDNEVHO79V./6G1P'4LR*%BVC&!WH ;;K_:+>7,P"QC XZ^]"_Z1,MHS+Y2Y
MPV.OM1"AU!A&JK%Y0P67O0L?G2+9A51H^2XH "NV8V0<>46^]CVZ43#[#*;>
M)E\N3&3CIS2>65D-CL4L6SYGX?SHD0V<C6Y593*!\[=>N* '7"C2P/)8-O&"
M/ZT2QC3XTGB8.[=5]:)HSI?+!9?,&T9[4DD)TU4G8"1?[OIGTH 5H!! MVLB
MF4G-'D+-;M=LX$N-V/3VI&M6MXUN3M89SY>>*4VYGA>\^4)]_P OL<>OO0 L
M,8U)9)I6".O ]N.M-MU_M1F$S!?+& ,?K2QPG4O-F4+%CY=N>N!WI(8SJC':
M!$(QC([T $/^F2?9Y&'EQ]#C[U(,O-]B+CR0?O?TI85-XPMPJQF+JRT@7=)]
MBVJ&#9W_ .>] "S#[+)]E1QY<A&3CI1<#^S&V0L"L@PW'3WHD0V[&T*J[2$?
M.?>DG7^S6*,%F,JX#-UH ?-$-+VR0L&9N"/7WI'A6SA2Y1U:0\GWI9(#I>V1
M]LH8;<'MGCCVI&M39HER=K#.?+[#Z4 )Y*FU^V;QYWWL8_2G10B^C>YD<+(#
MQ[4W[.?L_P!L^7;]_P OM2I;F_5[A0J#/W.QQZT +#$-2W-,P4H, 8_6FP#^
MT)/)F(V1CC_:]_\ /I3DA.IDNN(@HQ\O>FQ(=0D$2A8C",%EZ_YY_G0 1+]H
MD^R.Z^4A.#CK[4,/+E-F'7RB?O>G%$<?VAOL@54:-B=XZT&,QN;/:K%F^_WH
M +A?L#&&)@4DZ^U.FC&F,ODN#O&",?K39HS8EHF"RF7@,W6EDA.FD%@LN\;?
MF[9_I0 21C3DBN(F5G;J/7BE^SK'"MV)%,I.3^/:FM"=-$=PV) ?X?3C/%*+
M5HHUNOE(SN\OL,T $<*W,#7;.%ER3TZ8HAC&I(\TK!74<#TI%MS=0O= *JY)
M\OL<41PG4E>90(@!]T=_K0 MN@U+B9@ @P!CK[TV'_3)A;2,/+CS@X^]3H8S
MJ6 H6+RQM)7O38U^V2+;!5C:+)+CK^% !UG^P[QY.[[WX=*63_19C:1L/*?!
M)Q]WGI2;29/L.U=V[/F=^F?SI70VLC6I59&DP=Y_+F@ N%_LUMD+ K(,'V]Z
M6:,::JRQ,&9AR/6DF0Z:VQ@LIE&T,W:EDA.FJLK!901C![4 (T*VENETCAI2
M03[TH@62W-X7 F^]C^E(;<V<27)VN,Y\OL,^E*ML9(3=C:%SN\OM0 1Q"^CD
MN9'"R+T'IQ2PQC5&8S,%*# X_6D6 Z@LERN(Q_<]>_-+'"=29F4+$$&WY>_;
M\J &V_\ Q,6,4K )&./>G*OG2"T9U\I3UQUID*_V@PB4+$8A@LM.6(RL+3:J
MLISO% "2?N9A9JR^4[#YO3VHG']GR>3$PV2#!_V??_/K221F%OL>U6:0@[SU
MI94^PN86"RF88#-^?]* '31C2V4PL&\Q2",?3FB2%;&-+B)U9SU]Z22$Z6P9
M@LH=2/F[?YS0UJVGJD[!9!_<SP/I0 GDJMJ+P./.^]C'Z4HA6ZA>Z=U$HY'M
M3?LY6W%Y\I7[_E]O_P!=.^RFZC>Y&U1U\OL: %AC&I*TLS!64<#T]Z2W4:D^
MR9@%C4;>.OO1'"=4W3+MB4#&!W^M$,9U)]JA83$N"R]\T )$OVJ;[+(R^5'G
M!]>:3_EM]BWKY6[[V/TI8T-U(+4*L;1$_.OMQ2>6?,-EM7=NSYG^>] !,/L<
MGV:-AY<AY/\ =I;A?[-8)"P(D&#QT]Z)$^QL;8JLC2]'/6B9#IK;6"R^8, M
MVH 6:,:;Y<L3JS.<'W]Z'A6UMUNT8-+UV^N>U$D#::8Y6VRY^7:>WTI&MS:P
MI>':RC#^7V&?3WH 5(1-;F[+J)<Y_7I211C4(Y+B5@KKT7^[0MNTT)N@% W9
M\OMUH2$Z@DERNV-?[OK]: %MU&J9,S!=@P/\:2'_ $Z3R)& 2,'''7FEAC.J
M9*A8O+&T[>])"IOG6!56(Q _,OUH ,>9,MD7'E _>QUXZ4C_ .CS&S5AY+')
M;'3V_P ^E'EF21;(*JLK9,@^F?Z4,ODR&R*J[2$$.>O^>?YT /F7^SW\J)AL
MD&#[43QC2P'A96+#!']:22,V+&)@LOF@ ,W6B6$Z9AVVR[@1ANU "2Q"QA2Y
MC8-(>HQUS3A;KY N_,7S<YZ?I36MS8QI=-M=>NSTSZ4JVK>2+K"XSN\O/% "
MB%;N%[IV"R@9"^G'2B&,:GODF959.!_C2?9C>1/=KA%/S;/7OS[T1PG5"\BA
M8MOR8'?']* "W4:E\DS +&.!CK21C[3(+5V7RU)P?6B%#J6%4+#Y:XW+WH2,
MW#"U"JAC)RXH &&V468<>43][T]J)/\ 0YC;1L/+D R?[M(T95Q9;5+,V?,_
MSWI9(S:R-;%5E,N,.W]: %N%&EL!"P(D4Y&.GO3I(5TY5FB<,[#!]_>F31G2
MV^8";S%(!;J,4YK9M-"S-ME'3:>V?2@!IA$-NEVK@RGG'K[4IA62W:[+KYHY
MQZ>U)]G,$*79"LOWO+["@V[20M=C:%^]Y?:@!\<(U!&GE<*Z]/;WIELHU5F\
MXA?+4 #^M.6W;4%>90L8Z;1WQZTV%#JC':!#Y:@97O0 +')=M(]HIA0#:PW8
MR1V^M-C4W3 6B>2RKAVR0#3E:16?[#O,>/FR.]-CRK#[#N+[?WF0.M !&AE9
M884V7"$[GW4C*0WV<H3=ELB3/ZTJ97:8"YN\G=2-G=DEQ?;N/\^E !(IA9H9
MD,MQ)@(X:G2(UK)B[7SRR$(V20*23+,YN=PNN/+Q2R;FD_T_<&VGR\ #F@ :
M.2SV278\V+H%W9P30L,D<:32#=; [O+W'@5Z9X)^"=]XGT)==\2:K;^'/#__
M "RGN\;I?0J,C\._M6I>? :VU33'D\*^+K3Q'Y"[WL1'Y4K*/[N3S^5<<L91
MC+E<MO)V^_8ZUA:TH\R7^?W;G$_$#X;WW@&ZLXIKF&Y@O($N@D)8 *V#@Y'7
MFM+QEX;\2_#>33X[?7)XH;RT2Z6.SN9$ 5@#C&1S76?M.1W$'B#P_$59(5TV
M%7&!D8 R*ZSXH?#75O'6I>'IH+N'2M%MM'@^TZA=G")\HX'J<5Q1Q7NTI56K
M2O?]#KEA_>J1IK56L?/-YK6J>(F^>^NIMJC=]HN'?)_$U11#-)'% GE3Q@[W
M)_2O9;'X&Z!KC26OA3X@6-]JH7 MIX#&LC>@8G^0->9W7A:[T+Q9'HNH%]-U
M!91#=/(NX1@D?/UY&"#GN*[Z6(I5+QATZ6:_ XJE&I"SEUZWN8BJ686ZH5NU
M;)DS^M.:-HRT,B%[EC\LFZNG^(O@&[^'/B9M+FG^UWA59H[F-=JRHPSD GIG
M(^H-3?#GX>7GQ&UB[MA=?8'M83<2W4B;DC4#T![_ %K3VU/V?M;^[W,_93Y_
M9VU.2E4VI872><[#"L"<"AXWLV1KM3,C#:HW9P?2I=0A6&[N([B5I3&Q6*15
MVAL'@X]ZB9G9E^W;@F/DP.]:F8>7);K#-<#?;@YVYSM]Z1K>;R_-*G[-NSY.
M[G&:7,C+$+K=]DSQP/PS^%(6F\HJ2_V/=UQSC-,0>5)<1R30#;;$Y*;B,^M.
M6-[K<UHODH!AESC--_>JD@MMWV3OP/QQ2J9%W?8=YBQ\V1GF@!(U:Y95M4\E
MT&';=^E"H9&2"--ETI)9RWZ_C1'E64V>\RX_>9 H7(9#$7-YD[J  QG<UN4)
MNRX(DW?K^%$B&!WCN$\V=\;'!H.[<Q._[?N&*),LSFZ+"X&/+X_*@!9(VL\F
M[7S@R[5^8G!]*#&]H(Y;H>9#CA=V=M$A9L_;MX&WY, =:,R,(Q>;OL_;@4 )
MY,L<22R)NM]V?)W<TK0R2123QC;:D[O+W'D4TM*T:B7?]CW>G.*<3,L;B+>;
M//H.G?%  L;W?F/:J8HNA7.,\>E$:->/_HB^254!VW'FE#2+Y@LMWD?Q?ES5
MG2M+OM6O5M]#M;B\N&4;XX8]YS]*3:2NQI-Z(J1J9F2*!/*GCSO;- 4LPMUC
MQ=ALF3/ZU[1X1_95\6ZPD-Q=R0Z$&Y?[0?,D_P"^1Q^9KUGPW^R/X7TUUGU2
M\O=6N<Y;Y_*0_@O./QKRZV9X:EIS7?EJ>C3R_$5=>6WJ?'TB&$M#*ADN6(V2
M _UIQADCD,<\+7,LBXCVY;\*_0'3/@[X+TEE>#PWI[2+]V2:$2N/^!-DUU-K
MIMI8ILM[:&!?[L:!1^E>;+/(?8@W\_\ AST(Y//[4_P_X8_.B'PKK?R/)I-]
M>(5POEP.V">G05.O@+Q/$L;R^'M5D@SD1"TE)'X;:_1C:/0?E1@>E8?VY/I3
M_$V_L:/6?X'YR_\ " ^)_+,@\/:K]GSGR?LDN<?3;3O^$!\3S!WA\/:K%#_S
MS-I*"?PVU^C&!Z48'I1_;D_Y%]X_[&A_/^!^='_"!^)KAB;;P]JENH7#;K24
M;O\ QVD7P'XEF:-;?PYJMO(BX=FM)0/I]W_/X5^C&!Z48'I1_;D_Y%]X?V-#
M^?\  _.9/ ?B5E6)/#FJQW"L=TIM)<'WSMH/@/Q(,Q-X<U5K@MQ-]DE_GMK]
M&<#THP/2C^W)_P B^\/[&A_/^!^<S^!/$L0=)_#FJSR-C:ZVDI'_ *#3O^$#
M\36[C[1X=U2XRN%VVDIQ_P".U^B^!Z48'I1_;D_Y%]X?V-#^?\#\YQX#\30&
M)[CP]JDT79!9RDK^&VA? /BA521O#VJ&WW9\G[+*2!_WS7Z,8'I1@>E']N3_
M )%]X?V-#^?\#\Y?^$!\3R*\D?A[54@SGROLDH)_#;3CX#\37!D>W\/:I!'C
ME6M)1N_#;7Z,8'I1@>E']N3_ )%]X?V-#^?\#\YU\!^)9ROV?P[JEN57#%K2
M49_\=I%\">)9#''#X<U6*9<[I#:2@?GMK]&<#THP/2C^W)_R+[P_L:'\_P"!
M^<W_  @?B3B$>'-5^T[\^=]DEQ^>W_/UXH;P)XEC,D<OAS59)V(*RBTE(_/;
M7Z,X'I1@>E']N3_D7WA_8T/Y_P #\YV\"^)8&87'AS5+AF7"LMI*<>WW:/\
MA _$UOM>X\/:K.F,!1:2G'_CM?HQ@>E&!Z4?VY/^1?>']C0_G_ _.9? /B>)
M$DE\/:H\&<^5]DE)'X;:7_A ?%#(9%\/:J+?=GR?LLH/_H-?HQ@>E&!Z4?VY
M/^1?>']C0_G_  /SG/@/Q/-YLD'A[5(8<\QFTE!;\-M+_P ('XFN')M_#VJV
MX"@-NM)1G_QVOT7P/2C ]*/[<G_(OO#^QH?S_@?G-'X$\23;$@\.:K!(H^9F
MM)0#_P".TH\!^)658E\.:JEP&YE^R2_SVU^C&!Z48'I1_;D_Y%]X?V-#^?\
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M?GMH;P)XD7?$_AS57N&8$2BTEQ]<[>W^>E?HS@>E&!Z4?VY/^1?>']C0_G_
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M7UY!^E.M_+N(G>ZD*SCH"<8],4BP^=:M>-+^]SG'8>U+#"-1C>>5]CKQCTH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?F:MNVIL\B;8@ORD#N1388S
MJ1"H%A\M<$KQFE$;W3.UJ#$@^5AGJ?2DC4W3 6H,+(N&;UK]5/S0$0W+"U 5
M&C)RXZTA0JWV+"[R<^9_GO1&IE*PQ*8[A"=SYH*[6^SE3]J+9WY_6@ D4V;M
M;,%D:7&';M2R1G36PX6;S%(!;DBDD4PLT4ZF6X? 5\TLB-:N?M8,Q92$/I0
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M1]!TWP]:+:Z98V]C O2.",*/QQUJ_117F-N3NST4DE9!1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g523418img022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g523418img022.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M_.:]DQ*!C#<?+CT[_3_&G1P_;+=[UY=DV21Z+CM1##_:WFS32;63@8X ]S0
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M'8,VR<2*5^8=#_AS39(S:L\=TAN)95PC[L__ *J5HFL9 UX#<AE*I\V<'TH
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M #MYIL2XM_XL=^.<4C32QPR0QDM: [?.VY*CT]Z42O9^;'9GS8!R6QG9_C0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)ZDGN3R:TZ^'QN95,4^6.D>W?U/L,)E]/#+FEK+^M@HHHKR#U0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X*^/2FW^-7B:XG
M0FV^TJ/4 ^2G./R_*O/Y,2W!NDB8V2L-P Z^^/3K^==_\>F_XO9XD%QN%K]I
M7&?N[O)3_P"M_G->?R-']J(0M]@W+OVYV[O\Y_SBOTS"_P "GZ+\C\\Q'\:?
MJ_S'3XO9C-;1L84&)-O&[GI_+\J+MEU#:+&,Y53O*@#C^[_.FW31_:&^S%C!
MM'G>7TZ__J_SFG7S1@K]@)+[#OV9^[72<XLTD=]%%#:1E;A>IQC;ZY/UI&DB
MDLTM8X6%V,#&.5(ZDFB=H?)M_L))NNVW.>G.:1FM_L$?E$_:\C&,[MV: '>;
M%%;O;20DW9XQC)8GH0:6&2.Q62&\C+3-T.,[ACC!IH:V^QRF4G[7DYSG=N]J
MZ[X<Z1I5S;>(]<\26SWUMH=LEP]CO*?:))'6.)"PY";CDX]!43FH1YF7"+G+
ME14^',VN:1XBFFTBY>PU".SFN?,W85H(D,DB,""&^5?ND8^E='?>+DL=/TC6
MM?\  /A>>/6(Y9K:Y@AE@=@DA1C*B.%R2">!SUK7^'?C'2/$VIZU'?\ AC3=
M%U./1+]K&YTE'A4Q_9WW1R(6(8;<D-P01[U%<>(=#\/_  M^'<EUHMKK&J2V
MMX+=]45GMH(1=/D^6" SL2.2< +[UYM23E42<-=%Y[-[I[:?F=\(J--M3TW\
MMTMK;ZG)ZI\3=4O-/:RL[*Q\.>&YCB2QT6V$"S>AE;)9Q[%L>U<G)LDF^TQP
MG[&K#<!P#COC\_SKTFX;PUJ&D:+XV.AV]GIUMK']FZOI,.[[)/F,NLL2DY3*
MA@5!P" ?6G_\(+IOA+Q=XMN]2B6_\+:) +BW20DQ7KW Q9KP<D8;<<?\\S6T
M*M.FFE&S_-WM]^J^\RE2G-IN5_\ +?\ S^X\RNL7LOFVL9,*#]YM&-W/3'Y?
ME3[AX]09?L<1W*/F*C''I_.H[PHLQ^S,3#M'GE.F,_\ ZO\ .:DNFA#)]B+%
M]IW>7G[O?-=YQ!))%>1QPVL96X7J>FWCG)^M-,D4EFEJD1%X"!C'(/<TZ9H/
M)@^Q$FY_AV]>G>F%K?[!'Y1/VO(QUW;LT +YL4-J]M+$3=DXQC)8GH0:=')%
M9+)%=QDS-R#UW#'&#3=UO]AE\XG[7DYSG=NIT+0;)OMI(G[[\YQCC% #;5DT
M]F-[&0'4;-PS@>E):[;-Q-<Q,L#Y\O<,[>>*6R:+S&^VD@[!Y?F9^[3;-HO,
M7[06^S_-Y/F9QC- "Q[8YC=/$WV(N2H[#WQZ?X4LNV:87,<3&T5@7 & V.^/
MS_.FQM%]I^<M]A\P["<[<X__ %?YS1,T7VC]V6^Q;U\S;G&?\Y_SB@!UUB^D
M\VUB+1(/WFT8W>W\ORI;IDU!E^Q1\HIWD#''I_.F7SQ+*QMB?(V?OMG0#/\
MG_.:^C/@;^SBFM2V?B7Q';O!INW?;::X(-R#T>4'D)W"_P 74\=>;$8BGA8<
M]1_\$Z*%">(GR01D_ W]G_\ X3Z.SUS7K:2ST",AH;<@I+>$>_41^_5NW'-?
M75G9P:?:PVUK#';VT*"..&)0JHH&  !T J2.-8HU1%"(HPJJ,  = !3J^!Q>
M,J8N?-/;HNQ]OA<+#"PY8[]6%%%%<)V!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!\%?'N0W'QJ\2VTTFVW-RO7H3Y*<
M9_+\Z\_DQ#<?8TEQ9L1N/&!_LY_/\OK7H/QZ8WGQH\2V;;5C^TJV['/^I3BN
M D4PS'3@5\N1@=Q'(Z<?7FOTS#?P*?HOR/SS$?QI^K_,2?%C,8+:7;"XR^.=
MOOQ^'YT72KI>TV4F2ZG<!@\?WN*69?[,E:V0J5F7DL/N_6EN8_[%(:,A_,4J
M0P_7Z5TG.)-&EA%%/:2;YVZC@[\CGBFM'%%9K>1S9NS@YR,L3U'K3Y+<:3'%
M=(5D8]5QUR.W_P!:D-J+>U6_#*9,A\8^4Y/0>] #X;07D?GAV>^9L*J#+;NR
M@=:WO ?BVWT6XU)]5MTU'3K^V-G?Z>TGEEH<A@5;JKJP#*?7ZU0\.WS:1JUG
MX@4_O;683[(SMX'5<^I''3O77VOQ&M-5TFQ672Q%):J%,L00/ XA9/.B)SAR
MS;SN'4<YX(YJO,UR\MUZF].R][FLRSH/C#P;X;AU&73]+UJ[FU&QN;".^UF6
M%?)1XRK>4J#:QRR[F)SC@#FJ-CXZ\+>(/!OA[PKXCTV^>#2$F,>J64\:3;VE
M+857RK(5(R&Y!7(-&D_$C[5=)'/%<7]A \CR1731E[AF$05WPN,J8B1U^\.^
M26Z7\2O[0N-M[!,;J"7S#=6QB#7$:RNXMWRN/*PX4@?W!P1@#F=)[N+OWYO5
M?D=*J+925O3T91\8>)K&ZLM.\(Z397&D^'+.0W1%]*'N+R9UXDD( 4#9@*JC
M !SW%+XB^(5WKW@70O"PXT[2'Q<WBD'S%)(@1R.R*749_H:T8?B-8W%Q%83:
M4/(1?*DM?D:VN %0!I%QN+)L^4 ] HR,'=IW_P 1M*TB[LK.+?XA<S2RO=W<
M:JT(<D(J?(IR@((ST( !'8LURKV=VM=^HKI\SY]'IMT/*[AEL9O(M9L12#+[
M2#LYQGC_ #S4EPB::5-I+RX^8#!X]>*ZWQAXUM[[39]-ALVA>ZN(Y@^$55"Q
MA&9P.69MH/.<<G)R<\I-!_8[!HRK^8"I##GZUW0DY*\E8XY)1=HNXR6*.QCC
MGMI=T[=1P=_'I2&...U2\2;-V2#G(RQ/4>M/>V&DQQW2%78]5/?(SQ_]:F_9
MO)MDOPRF0G=MQP<GH/>M"!/*CFM7NY)MMTO.<C*D=!ZTZ.&/4%DENI=LJ< '
M VCUQ1]E%S;O?LRK)]X#' QV/O3EMAJRRW#LJ,O  '3 ZF@".U5=49A>29V*
M-@.!D?WN:+;%\P@N)=T*9V9XWX/O3K>/^VF(D*J(E"C:.OO]*2W0ZDRVSE L
M.0"@^]]* &QXDF^QO-_H:L0I['VST_\ UT\0N;R/3K5GEBFD6,)&NYMQ_A '
M4GT]OK6[X+\!Z[\0M6;0M%LOM2POF6YV[8H1ZN_\)_4^]?87P?\ @%HWPMMT
MN9"NJZXW+7LB86+/58AV'N>3[#BO-QF.I816>LNW];'H87!5,4]-(]SB/@=^
MS/'H$D6N^)X]]QQ);Z0^&2%NH>3LS?[/0=\GI]%445\-B,14Q4^>H_\ @'V5
M##T\/#DIH****Y3I"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ^"OC\?MGQE\2VJHJO]I5O-[@>2GZ\?RKS]HS"
MS6!1'ED8,)3Z>OUY_G7J7QU\,:QJ/Q<\12V.AZE*SW*LEU#:R,A'E(,A@N#T
M(_"N#;P9XA7=&_AW5WO&<%9OL<N/KG;Q_GTK])PTX^PIZ]%^1^?XB,O;3TZO
M\S*:,Z>[P.BSM,/E=NO7_P"M_*B2(Z.=TJK<"12@SV/I].:U6\%^(8VE6Z\/
M:O<3,H"2"SE(_P#0>*5O!GB*%LWGA_5[H%"%VV<IP?3[OZUT^TCW.?DEV,G[
M.=+$=U*%E3NG]W/I2?96@A6\94:,'>8>P!]*UU\%^(X?)>ZT#5YX .(Q9RG;
MQW&WFFKX+\2+'&\GA_5VM-V?(^R2D@?]\T>TCW0<DNQEM9M<1O>*%5"=XA[$
M#UI5MVU7S+B("%>@7^]CUK4;P5XD9)'CT#5UM2V?)^R2@D?]\\4K>"_$<S2M
M:Z!J\$)'*&SE&[CL-M'M(]PY)=C)CA.K2$QJMN(E"$KW/I]*2./^T&6W1%@>
M $,Z_7M^=:X\&^(II,V?A_5[;:@#EK.49/I]W]:2/P9X@D\I;;P]J]O,@.^1
MK.49_P#'>:/:1[AR2[&4(S*5L BK*C$F4>GK]>/Y4-$T.;(HCR2,"LIZ_7]?
MYUJ_\(9XA8)&GAW5UNPY)F^QR_GG;_G\:&\%^(=KQR>'M7DNV<%9OL<N/KG;
MQ_GTH]I'N')+L9,B?V>S0.BSM.,*[=?Q_*GM;G2F#2!;@.I0;NQ]/IS6G)X,
M\01M*MUX>U>YE90$D6SE('_CO%65^'_BE6#77AK6;I63"%;.4X_\=_6E[2'=
M!R2[&%]E;3/+N9 LJ=T_NY&>*;]E:&%;TA3'G?Y/8 ^E=79_"/QS</"9/"FL
M7$':-K=EV_7=BM[2?V;/B+J7E[M#^RVF_/E7EY&FT>^"3^E9RQ-&/Q37WHUC
MAZTMH/[F>;-:M<QO>*%5"=_D]B!ZT\VK:F9)XPL*]-H_B(]:]_T;]C;7;J3_
M (FGB&STZS9LM;V:/.V/J=H'Y&O4?#/[*_@C06\RZANM9E(^9;N8B(_]LUP/
MSS7GU,UPM/:5WY';3RS$U-U;U/C_ ,.^%=6\?7WV70]-FN9HU",+9"P!_P!I
MNBCZFOH+X?\ [(;W$=I<^,KI(!'S_9NFORWL\O;W"_\ ?5?2NEZ38Z+9I::?
M9P6-JGW8;>,1H/P Q5NO"Q&<5JGNTERK\3VJ&54J>M1\S_ SM!\.Z9X6TN+3
MM(L8-.LHA\D-N@5?J?4^YY-:-%%> VY.[/;225D%%%%(84444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
